FibroGen Inc (FGEN)
1.165
+0.04
(+4.02%)
USD |
NASDAQ |
May 01, 16:00
1.165
0.00 (0.00%)
After-Hours: 20:00
FibroGen Price: 1.165 for May 1, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 30, 2024 | 1.05 | 1.16 | 1.03 | 1.12 | 1.118M |
Apr 29, 2024 | 1.06 | 1.17 | 1.02 | 1.09 | 1.202M |
Apr 26, 2024 | 1.04 | 1.06 | 0.9754 | 1.04 | 653815.0 |
Apr 25, 2024 | 0.95 | 1.025 | 0.9010 | 1.02 | 1.259M |
Apr 24, 2024 | 1.06 | 1.098 | 0.9327 | 0.9843 | 2.171M |
Apr 23, 2024 | 1.15 | 1.26 | 1.05 | 1.07 | 1.349M |
Apr 22, 2024 | 1.15 | 1.17 | 1.08 | 1.14 | 803876.0 |
Apr 19, 2024 | 1.16 | 1.18 | 1.05 | 1.15 | 1.313M |
Apr 18, 2024 | 1.26 | 1.29 | 1.14 | 1.17 | 1.278M |
Apr 17, 2024 | 1.30 | 1.33 | 1.24 | 1.27 | 1.031M |
Apr 16, 2024 | 1.28 | 1.35 | 1.25 | 1.30 | 863694.0 |
Apr 15, 2024 | 1.30 | 1.37 | 1.24 | 1.31 | 1.265M |
Apr 12, 2024 | 1.35 | 1.35 | 1.23 | 1.30 | 1.140M |
Apr 11, 2024 | 1.45 | 1.465 | 1.35 | 1.36 | 1.162M |
Apr 10, 2024 | 1.49 | 1.51 | 1.36 | 1.43 | 1.356M |
Apr 09, 2024 | 1.62 | 1.63 | 1.485 | 1.51 | 1.014M |
Apr 08, 2024 | 1.63 | 1.69 | 1.56 | 1.63 | 1.198M |
Apr 05, 2024 | 1.56 | 1.695 | 1.51 | 1.62 | 1.620M |
Apr 04, 2024 | 1.41 | 1.815 | 1.385 | 1.58 | 4.161M |
Apr 03, 2024 | 2.14 | 2.15 | 1.180 | 1.47 | 10.34M |
Apr 02, 2024 | 2.28 | 2.33 | 2.10 | 2.16 | 932124.0 |
Apr 01, 2024 | 2.35 | 2.398 | 2.17 | 2.36 | 1.276M |
Mar 28, 2024 | 2.58 | 2.59 | 2.31 | 2.35 | 1.357M |
Mar 27, 2024 | 2.46 | 2.68 | 2.30 | 2.58 | 1.846M |
Mar 26, 2024 | 2.67 | 2.79 | 2.410 | 2.44 | 1.540M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.3801
Minimum
Nov 10 2023
55.72
Maximum
Feb 12 2021
23.03
Average
18.51
Median
Apr 11 2023
Price Benchmarks
Annovis Bio Inc | 6.11 |
Emergent BioSolutions Inc | 1.925 |
Geron Corp | 4.075 |
Vertex Pharmaceuticals Inc | 402.43 |
Regulus Therapeutics Inc | 2.495 |
Price Related Metrics
PS Ratio | 0.7671 |
Earnings Yield | -251.5% |
Market Cap | 115.07M |